Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2014 May 29;113(4):452–459. doi: 10.1016/j.anai.2014.04.024

Table 2.

Associations of Clinical and Radiological Characteristics

Ground Glass Opacitya ≥ 5 Pulmonary Nodulesa Bronchiectasis Only No Lung Diseaseb
Number of Subjects 18 34 9 13
Female (%) 20 (56) 20 (59) 5 (56) 7 (54)
Median Age (% > 50 years) 44 (33) 45 (35) 60 (67) 43 (39)
Subjects (%) with:
    Ground Glass 18(100) 13 (38) 0 (0) 0 (0)
    ≥ 1 Nodule 16 (89) 34 (100) 4 (44) 3 (23)
    Bronchiectasis 6 (33) 12 (35) 9 (100) 0 (0)
    Hilar Adenopathy 11 (61) 24 (71) 3 (33) 0 (0)
    History of Pneumonia 8 (44) 21 (62) 7 (78) 7 (54)
    Splenomegaly/Splenectomy 10 (56) 24 (71) 1 (11) 1 (8)
    AIHA/ITP 9 (50) 21 (62) 0 (0) 1 (8)
    Liver Disease 5 (28) 6 (18) 0 (0) 0 (0)
    Enteropathy 2 (11) 3 (9) 1 (11) 1 (8)
ILD No ILD
Number of Subjects 39 22
Subjects (%) with: p value
    History of Pneumonia 22 (56) 14 (64) 0.78
    Splenomegaly/Splenectomy 24 (63) 2 (9) <0.0001
    AIHA/ITP 22 (56) 1 (5) <0.0001
    Liver Disease 8 (21) 0 (0) 0.042
    Enteropathy 4 (10) 2 (9) 1.00

AIHA = autoimmune hemolytic anemia ILD = interstitial lung disease ITP = immune thrombocytopenic purpura

a

patients included in both groups if both ground glass opacity and > 5 pulmonary nodules were present

b

includes patients with no CT findings and those with 1-4 pulmonary nodules but no bronchiectasis or ground glass opacity